<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prostate Cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/prostate-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 14:23:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Prostate Cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Metabolomics Predicts Prostate Cancer Risk: Review Insights</title>
		<link>https://bioengineer.org/metabolomics-predicts-prostate-cancer-risk-review-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 14:22:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer biomarkers]]></category>
		<category><![CDATA[Early Detection]]></category>
		<category><![CDATA[Metabolomics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[systematic review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/metabolomics-predicts-prostate-cancer-risk-review-insights/</guid>

					<description><![CDATA[The intricate role of metabolomic dysregulation in the pathogenesis of prostate cancer (PCa) has emerged as a focal point of investigation within the oncological community. Recent studies illuminate the promising potential of circulating metabolites as clinical biomarkers, which could represent a transformative advancement in early cancer detection and management. While the concept of using biochemical [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318964</post-id>	</item>
		<item>
		<title>Exploring Cathepsin Z’s Role in Prostate Cancer</title>
		<link>https://bioengineer.org/exploring-cathepsin-zs-role-in-prostate-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 27 Oct 2025 08:27:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer biomarkers]]></category>
		<category><![CDATA[cathepsin Z]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[therapeutic resistance]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-cathepsin-zs-role-in-prostate-cancer/</guid>

					<description><![CDATA[Recent studies have illuminated the multifaceted role of cathepsin Z in prostate cancer, a topic that has sparked intense discussion and debate in the scientific community. The exploration into this cysteine protease has shifted paradigms about how we understand tumor progression, metastasis, and even therapy resistance. An article by Zhu, Qin, Jiang, and others brings [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">287085</post-id>	</item>
		<item>
		<title>Bidirectional impact of cardiovascular disease, cancer in Blacks focus of new AHA center</title>
		<link>https://bioengineer.org/bidirectional-impact-of-cardiovascular-disease-cancer-in-blacks-focus-of-new-aha-center/</link>
					<comments>https://bioengineer.org/bidirectional-impact-of-cardiovascular-disease-cancer-in-blacks-focus-of-new-aha-center/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jul 2021 04:14:10 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Eating Disorders/Obesity]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Minorities]]></category>
		<category><![CDATA[Physiology]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Stroke]]></category>
		<guid isPermaLink="false">https://bioengineer.org/bidirectional-impact-of-cardiovascular-disease-cancer-in-blacks-focus-of-new-aha-center/</guid>

					<description><![CDATA[Credit: Kim Ratliff, Augusta University Cardiovascular disease and cancer, the nation&#8217;s top two killers, share common ground like obesity and chronic inflammation, as well as a disproportionate impact on Black Americans. A new American Heart Association-funded center at the Medical College of Georgia is working to better understand the bidirectional dynamic, including how to intervene [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/bidirectional-impact-of-cardiovascular-disease-cancer-in-blacks-focus-of-new-aha-center/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174306</post-id>	</item>
		<item>
		<title>Chemo upsets gut health in cancer patients</title>
		<link>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/</link>
					<comments>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jul 2021 15:21:47 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mortality/Longevity]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/</guid>

					<description><![CDATA[New study challenges role of microbiome disruption Credit: SA Health and Medical Research Institute (SAHMRI) New research in BMC Cancer has shown myelosuppressive chemotherapy destabilises gut microbiome in patients with solid organ cancers. The study from SAHMRI and Flinders University assessed the gut health of men and women who underwent conventional chemotherapy on cancers, such [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173047</post-id>	</item>
		<item>
		<title>Prostate cancer linked to obesity</title>
		<link>https://bioengineer.org/prostate-cancer-linked-to-obesity/</link>
					<comments>https://bioengineer.org/prostate-cancer-linked-to-obesity/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 10 Jun 2021 12:25:46 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Diet/Body Weight]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/prostate-cancer-linked-to-obesity/</guid>

					<description><![CDATA[An INRS team is investigating the relationship between body mass and the risk of developing cancer Prostate cancer is the most common form of cancer among Canadian men and the third leading cause of cancer death. Abdominal obesity appears to be associated with a greater risk of developing aggressive prostate cancer. This link was demonstrated [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/prostate-cancer-linked-to-obesity/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171427</post-id>	</item>
		<item>
		<title>Protein in prostate cancer may inhibit tumor growth</title>
		<link>https://bioengineer.org/protein-in-prostate-cancer-may-inhibit-tumor-growth/</link>
					<comments>https://bioengineer.org/protein-in-prostate-cancer-may-inhibit-tumor-growth/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 09 Jun 2021 22:41:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/protein-in-prostate-cancer-may-inhibit-tumor-growth/</guid>

					<description><![CDATA[Researchers identified the protein responsible for cancer&#8217;s aggressiveness Prostate cancer is the second most common cancer among men, according to the American Cancer Society. It&#8217;s also one of the trickiest cancers to diagnose and treat. But new research from the University of Georgia has identified a protein that appears to prevent the cancer from spreading [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/protein-in-prostate-cancer-may-inhibit-tumor-growth/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171413</post-id>	</item>
		<item>
		<title>Oncotarget: The drug sensitivity of hepatocellular cancer cells</title>
		<link>https://bioengineer.org/oncotarget-the-drug-sensitivity-of-hepatocellular-cancer-cells/</link>
					<comments>https://bioengineer.org/oncotarget-the-drug-sensitivity-of-hepatocellular-cancer-cells/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 07 Jun 2021 18:36:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Carcinogens]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Policy/Ethics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/oncotarget-the-drug-sensitivity-of-hepatocellular-cancer-cells/</guid>

					<description><![CDATA[&#8216;Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death worldwide, with a poor median survival time after diagnosis of six months&#8217; Oncotarget published &#8220;Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells&#8221; which reported that this study aimed to investigate whether Hepatocellular Cancer (HCC) cells cultured in more native [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/oncotarget-the-drug-sensitivity-of-hepatocellular-cancer-cells/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171105</post-id>	</item>
		<item>
		<title>UCI-led study sheds light on mysterious genotype-phenotype associations</title>
		<link>https://bioengineer.org/uci-led-study-sheds-light-on-mysterious-genotype-phenotype-associations/</link>
					<comments>https://bioengineer.org/uci-led-study-sheds-light-on-mysterious-genotype-phenotype-associations/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 01 Jun 2021 20:18:48 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[alternative polyadenylation]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[disease heritability]]></category>
		<category><![CDATA[genotype-phenotype associations]]></category>
		<category><![CDATA[human complex traits]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[quantitative trait loci]]></category>
		<guid isPermaLink="false">https://bioengineer.org/uci-led-study-sheds-light-on-mysterious-genotype-phenotype-associations/</guid>

					<description><![CDATA[New data contributes to knowledge about molecular mechanisms underlying human traits and diseases Irvine, CA &#8211; June 1, 2021 &#8211; A new study analyzing the association between an individual&#8217;s genetics (genotype) and their observable characteristics resulting from the interaction of genetics and the environment (phenotype), contributes new knowledge to the understanding of human complex traits [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/uci-led-study-sheds-light-on-mysterious-genotype-phenotype-associations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">170666</post-id>	</item>
		<item>
		<title>UVA develops new tools to battle cancer, advance genomics research</title>
		<link>https://bioengineer.org/uva-develops-new-tools-to-battle-cancer-advance-genomics-research/</link>
					<comments>https://bioengineer.org/uva-develops-new-tools-to-battle-cancer-advance-genomics-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 May 2021 13:49:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Genes]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Health Care Systems/Services]]></category>
		<category><![CDATA[Health Professionals]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/uva-develops-new-tools-to-battle-cancer-advance-genomics-research/</guid>

					<description><![CDATA[Credit: Courtesy Zang lab at UVA University of Virginia School of Medicine scientists have developed important new resources that will aid the battle against cancer and advance cutting-edge genomics research. UVA&#8217;s Chongzhi Zang, PhD, and his colleagues and students have developed a new computational method to map the folding patterns of our chromosomes in three [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/uva-develops-new-tools-to-battle-cancer-advance-genomics-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">170181</post-id>	</item>
		<item>
		<title>New insights into androgen&#8217;s action could boost battle against prostate cancer</title>
		<link>https://bioengineer.org/new-insights-into-androgens-action-could-boost-battle-against-prostate-cancer/</link>
					<comments>https://bioengineer.org/new-insights-into-androgens-action-could-boost-battle-against-prostate-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 19 May 2021 13:45:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Physiology]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Sex-Linked Conditions]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-insights-into-androgens-action-could-boost-battle-against-prostate-cancer/</guid>

					<description><![CDATA[Credit: Angela Paschal Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells &#8211; and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers. The findings shed light on how androgens interact with their receptors inside cells to affect [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-insights-into-androgens-action-could-boost-battle-against-prostate-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">169593</post-id>	</item>
		<item>
		<title>Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy</title>
		<link>https://bioengineer.org/oncotarget-cabyr-a-b-and-cabyr-c-hold-promise-as-targets-for-specific-immunotherapy/</link>
					<comments>https://bioengineer.org/oncotarget-cabyr-a-b-and-cabyr-c-hold-promise-as-targets-for-specific-immunotherapy/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 17 May 2021 15:44:13 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Carcinogens]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/oncotarget-cabyr-a-b-and-cabyr-c-hold-promise-as-targets-for-specific-immunotherapy/</guid>

					<description><![CDATA[CABYR expression in tumors was further confirmed by immunohistochemistry Credit: Correspondence to &#8211; Richard L. Whelan &#8211; Rwhelan1@northwell.edu Oncotarget published &#8220;The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy&#8221; which reported that Calcium-binding tyrosine phosphorylation-regulated protein is expressed in the human [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/oncotarget-cabyr-a-b-and-cabyr-c-hold-promise-as-targets-for-specific-immunotherapy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">169373</post-id>	</item>
		<item>
		<title>Engineering T cells to attack cancer broadly</title>
		<link>https://bioengineer.org/engineering-t-cells-to-attack-cancer-broadly/</link>
					<comments>https://bioengineer.org/engineering-t-cells-to-attack-cancer-broadly/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 30 Apr 2021 16:19:19 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/engineering-t-cells-to-attack-cancer-broadly/</guid>

					<description><![CDATA[A new approach to immunotherapy arrests solid tumor growth for a variety of cancers and squashes the spread of cancer to other tissues, in mice. Credit: Shawn Wang, Ph.D. Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it&#8217;s possible to arrest tumor growth for a variety of cancers and [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/engineering-t-cells-to-attack-cancer-broadly/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">168070</post-id>	</item>
		<item>
		<title>Decrease in prostate cancer diagnoses due to pandemic</title>
		<link>https://bioengineer.org/decrease-in-prostate-cancer-diagnoses-due-to-pandemic/</link>
					<comments>https://bioengineer.org/decrease-in-prostate-cancer-diagnoses-due-to-pandemic/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 29 Apr 2021 15:36:29 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/decrease-in-prostate-cancer-diagnoses-due-to-pandemic/</guid>

					<description><![CDATA[Credit: Mikael Wallerstedt During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years. On the other hand, the number of patients receiving curative treatment for prostate cancer was unaffected. This is shown by a new register study led by Uppsala University [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/decrease-in-prostate-cancer-diagnoses-due-to-pandemic/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">167954</post-id>	</item>
		<item>
		<title>City of Hope opens Phase 2 trial to test if mushroom tablets could slow prostate cancer</title>
		<link>https://bioengineer.org/city-of-hope-opens-phase-2-trial-to-test-if-mushroom-tablets-could-slow-prostate-cancer/</link>
					<comments>https://bioengineer.org/city-of-hope-opens-phase-2-trial-to-test-if-mushroom-tablets-could-slow-prostate-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 29 Apr 2021 04:17:13 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Nutrition/Nutrients]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/city-of-hope-opens-phase-2-trial-to-test-if-mushroom-tablets-could-slow-prostate-cancer/</guid>

					<description><![CDATA[Scientists investigate if City of Hope&#8217;s natural supplement derived from white button mushroom could lower prostate-specific antigen levels, an indicator of prostate cancer Credit: City of Hope DUARTE, Calif. &#8212; City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/city-of-hope-opens-phase-2-trial-to-test-if-mushroom-tablets-could-slow-prostate-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">167908</post-id>	</item>
		<item>
		<title>12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers</title>
		<link>https://bioengineer.org/12-open-arms-in-nci-match-treatment-trial-await-patients-with-advanced-or-rare-cancers/</link>
					<comments>https://bioengineer.org/12-open-arms-in-nci-match-treatment-trial-await-patients-with-advanced-or-rare-cancers/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Apr 2021 17:39:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/12-open-arms-in-nci-match-treatment-trial-await-patients-with-advanced-or-rare-cancers/</guid>

					<description><![CDATA[A new study arm opens, expanding patients&#8217; potential to qualify for the trial when they may not have other options; the available treatments target tumor defects with drugs that show efficacy evidence; testing labs continue to identify trial candidates Credit: University of Pennsylvania The NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) cancer clinical trial is expanding [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/12-open-arms-in-nci-match-treatment-trial-await-patients-with-advanced-or-rare-cancers/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">167583</post-id>	</item>
		<item>
		<title>First clinical trials set for MRI cancer detection</title>
		<link>https://bioengineer.org/first-clinical-trials-set-for-mri-cancer-detection/</link>
					<comments>https://bioengineer.org/first-clinical-trials-set-for-mri-cancer-detection/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Apr 2021 15:56:56 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/first-clinical-trials-set-for-mri-cancer-detection/</guid>

					<description><![CDATA[Case Western Reserve University-developed imaging agent for MRI prostate cancer detection gets FDA approval for safety trials, set to begin in May in Columbus Credit: Case Western Reserve University CLEVELAND&#8211;The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/first-clinical-trials-set-for-mri-cancer-detection/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">167385</post-id>	</item>
		<item>
		<title>Grant aims to reduce prostate cancer disparities among black men</title>
		<link>https://bioengineer.org/grant-aims-to-reduce-prostate-cancer-disparities-among-black-men/</link>
					<comments>https://bioengineer.org/grant-aims-to-reduce-prostate-cancer-disparities-among-black-men/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 21 Apr 2021 20:38:09 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Health Care Systems/Services]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/grant-aims-to-reduce-prostate-cancer-disparities-among-black-men/</guid>

					<description><![CDATA[$250,000 grant funded by Pfizer Global Medical Grants and overseen by the American Cancer Society is Aimed at Reducing Gaps in Care and Barriers to Treatment Credit: Henry Ford Health System DETROIT &#8211; Henry Ford Cancer Institute has received a $250,000 grant from Pfizer Global Medical Grants and the American Cancer Society to reduce prostate [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/grant-aims-to-reduce-prostate-cancer-disparities-among-black-men/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">167266</post-id>	</item>
		<item>
		<title>NYU Abu Dhabi researchers develop Micro-Fluidic Probe to isolate cancer spreading cells</title>
		<link>https://bioengineer.org/nyu-abu-dhabi-researchers-develop-micro-fluidic-probe-to-isolate-cancer-spreading-cells/</link>
					<comments>https://bioengineer.org/nyu-abu-dhabi-researchers-develop-micro-fluidic-probe-to-isolate-cancer-spreading-cells/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Apr 2021 15:33:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nyu-abu-dhabi-researchers-develop-micro-fluidic-probe-to-isolate-cancer-spreading-cells/</guid>

					<description><![CDATA[The Herringbone Microfluidic Probe more effectively isolates cancerous cells to track metastasis utilizing a non-invasive liquid biopsy Credit: NYU Abu Dhabi Abu Dhabi, UAE, April 19: The survival rate of cancer patients can drop to ten percent or less during metastasis, the spread of cancerous cells to create secondary tumors. Therefore, it is crucial that [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/nyu-abu-dhabi-researchers-develop-micro-fluidic-probe-to-isolate-cancer-spreading-cells/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">166971</post-id>	</item>
		<item>
		<title>Study: New approach may boost prostate cancer immunotherapies</title>
		<link>https://bioengineer.org/study-new-approach-may-boost-prostate-cancer-immunotherapies/</link>
					<comments>https://bioengineer.org/study-new-approach-may-boost-prostate-cancer-immunotherapies/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Apr 2021 18:37:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-new-approach-may-boost-prostate-cancer-immunotherapies/</guid>

					<description><![CDATA[Strategy focuses on reprogramming tissues surrounding the tumor to help the body&#8217;s immune system attack the cancer Credit: Cedars-Sinai LOS ANGELES (April 15, 2021) &#8212; Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body&#8217;s immune cells fight the cancer. The discovery, made in human and mouse cells [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-new-approach-may-boost-prostate-cancer-immunotherapies/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">166788</post-id>	</item>
		<item>
		<title>John D. Carpten elected fellow of AACR Academy</title>
		<link>https://bioengineer.org/john-d-carpten-elected-fellow-of-aacr-academy/</link>
					<comments>https://bioengineer.org/john-d-carpten-elected-fellow-of-aacr-academy/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 29 Mar 2021 16:03:30 +0000</pubDate>
				<category><![CDATA[Science News]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genes]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Research/Development]]></category>
		<category><![CDATA[Researchers/Scientists/Awards]]></category>
		<guid isPermaLink="false">https://bioengineer.org/john-d-carpten-elected-fellow-of-aacr-academy/</guid>

					<description><![CDATA[American Association for Cancer Research honors distinguished USC Norris Comprehensive Cancer Center scientist Credit: Keck School of Medicine of USC John D. Carpten, PhD, founding chair for the Department of Translational Genomics in the Keck School of Medicine of USC, has been named to the 2021 class of fellows of the American Association for Cancer [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/john-d-carpten-elected-fellow-of-aacr-academy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">165074</post-id>	</item>
	</channel>
</rss>
